Takeda to Present at the 34th Annual J.P. Morgan Healthcare Conference
Details of the timing, and how to access the audio webcast and presentation materials, are as follows.
Date and time
Tuesday January 12, at 11:30am - 12:30pm (Pacific Standard Time)
[Wednesday January 13, at 4:30am - 5:30am (Japan Standard Time)]
Agenda
· Presentation (25 minutes): Takeda Strategic Update
Christophe Weber, President and Chief Executive Officer
(Note: Includes updates on ENTYVIO® sales from Oct-Dec 2015, and Takeda's direction in R&D)
· Q&A session (25 minutes)
Christophe Weber, President and Chief Executive Officer
Andrew Plump, Chief Medical & Scientific Officer
Rudolf van Houten, acting Chief Financial Officer
Christophe Bianchi, President, Global Oncology Business Unit
Access to audio webcast
http://bit.ly/1TH6bTS
· Registration is required in advance, so please visit the URL a few minutes before the presentation is scheduled to begin.
· In addition to a live webcast, the audio will also be available on-demand at this URL for 90 days following the event.
Access to presentation materials
Presentation materials will be uploaded to Takeda's website at the same time as the presentation begins:
http://bit.ly/1O6KRFX
Note: Audio and materials are available only in English.
About Takeda Pharmaceutical Company Limited
Located in Osaka, Japan, Takeda (TOKYO: 4502) (http://goo.gl/eX9kbP) is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to strive towards better health for people worldwide through leading innovation in medicine. Additional information about Takeda is available through its corporate website, www.takeda.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160107006438/en/
Website: https://www.takeda.com/
Contact
Takeda Pharmaceutical Company Limited
Media Contacts:
Tsuyoshi Tada
+81 3-3278-2417
tsuyoshi.tada@takeda.com
Investor Contacts:
Noriko Higuchi
+81 3-3278-2306
noriko.higuchi@takeda.com
This news is a press release provided by Takeda Pharmaceutical Company Limited. Korea Newswire follows these editorial guidelines.
-
14:57
-
13:33